Abstract
More and more studies indicate interactions between infectious diseases and microbiota. Advances in molecular techniques have led to a greater appreciation of the diversity of human microbiota, the extent of interactions with the human host, and how that relates to inter-individual variation. Realization of the interaction between infectious agents and the microbiota will definitely deepen our understanding of infectious diseases.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Acute Myeloid Leukemia
- Irritable Bowel Syndrome
- Clostridium Difficile Infection
- Lactobacillus Reuteri
- Saccharomyces Boulardii
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Konopka A. What is microbial community ecology? ISME J, 2009, 3: 1223–1230.
Raes J, Bork P. Molecular eco-systems biology: towards an understanding of community function. Nat Rev Microbiol, 2008, 6: 693–699.
Xu J, Mahowald M A, Ley R E, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol, 2007, 5: e156.
Gorbach S L, Barza M, Giuliano M, et al. Colonization resistance of the human intestinal microflora: Testing the hypothesis in normal volunteers. Eur J Clin Microbiol Infect Dis, 1988, 7: 98–102.
Bjerketorp J, Ng Tze Chiang A, Hjort K, et al. Rapid lab-on-a-chip profiling of human gut bacteria. J Microbiol Methods, 2008, 72: 82–90.
Verberkmoes N C, Russell A L, Shah M, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J, 2009, 3: 179–189.
Tuohy K M, Gougoulias C, Shen Q, et al. Studying the human gut microbiota in the trans-omics era — focus on metagenomics and metabonomics. Curr Pharm Des, 2009, 15: 1415–1427.
Fujimura K E, Slusher NA, Cabana M D, et al. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther, 2010, 8:435–454.
Bik E M, Long C D, Armitage G C, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J, 2010, 4: 962–974.
Keijser B J, Zaura E, Huse S M, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res, 2008, 87: 1016–1020.
Zaura E, Keijser B J, Huse S M, et al. Defining the healthy ‘core microbiome’ of oral microbial communities. BMC Microbiol, 2009, 9: 259.
Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature, 2010, 466:334–338.
van Vliet M J, Harmsen H J, de Bont E S, et al. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog, 2010, 62: 1223–1236.
Manichanh C, Varela E, Martinez C, et al. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol, 2008, 103:1754–1761.
Stecher B, Chaffron S, Kappeli R, et al. Like will to like: Abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog, 2010, 6: e1000711.
Bailey M T, Dowd S E, Parry N M, et al. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun, 2010, 78:1509–1519.
[17] Walk S T, Young V B. Emerging insights into antibiotic-associated diarrhea and clostridium difficile infection through the lens of microbial ecology. Interdiscip Perspect Infect Dis, 2008, 125081.
Wilson K H. The microecology of Clostridium difficile. Clin Infect Dis, 1993, 16: S214–S218.
van Vliet M J, Tissing W J, Dun C A, et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis, 2009, 49: 262–270.
Zhang M, Zhang C, Du H, et al. Pattern extraction of structural responses of gut microbiota to rotavirus infection via multivariate statistical analysis of clone library data. FEMS Microbiol Ecol, 2009, 70: 21–29.
Gori A, Tincati C, Rizzardini G, et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol, 2008, 46:757–758.
Tanaka K, Sawamura S, Satoh T, et al. Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus. J Immunol, 2007, 178: 5209–5216.
Filoche S, Wong L, Sissons C H. Oral biofilms: Emerging concepts in microbial ecology. J Dent Res, 2010, 89: 8–18.
Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis, 2009, 41: 844–849.
Bohle L A, Brede D A, Diep D B, et al. The mucus adhesion promoting protein (MapA) of Lactobacillus reuteri is specifically degraded to an antimicrobial peptide. Appl Environ Microbiol, 2010, 76:7306–7309.
Medellin-Pena M J, Griffiths M W. Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157: H7 colonization. Appl Environ Microbiol, 2009, 75: 1165–1172.
Doron S I, Hibberd P L, Gorbach S L. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol, 2008, 42: S58-S63.
Surawicz C M, McFarland L V, Greenberg R N, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis, 2000, 31: 1012–1017.
Anukam K C, Osazuwa E O, Osadolor H B, et al. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol, 2008, 42: 239–243.
Reid G, Bruce A W. Low vaginal pH and urinary-tract infection. Lancet, 1995, 346: 1704.
Rea M C, Clayton E, O’Connor PM, et al. Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J Med Microbiol, 2007, 56: 940–946.
Shanahan F. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Host-microbe interactions in the gut: Target for drug therapy, opportunity for drug discovery. Clin Exp Immunol, 2010, 160: 92–97.
[33] Mai V, Ukhanova M, Visone L, et al. Bacteriophage administration reduces the concentration of listeria monocytogenes in the gastrointestinal tract and its translocation to spleen and liver in experimentally infected mice. Int J Microbiol, 2010, 624234.
Possemiers S, Bolca S, Verstraete W, et al. The intestinal microbiome: A separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia, 2010, 82: 53–66.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Zhejiang University Press, Hangzhou and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Li, L., Chen, Y. (2014). Future Development of Infectious Microecology. In: Li, L. (eds) Infectious Microecology. Advanced Topics in Science and Technology in China. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43883-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-662-43883-1_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43882-4
Online ISBN: 978-3-662-43883-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)